Teva Pharmaceutical Industries reported $47.85B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
ALKERMES ALKS:US $ 1995.43M 57.86M
Amarin AMRN:US $ 1035.8M 9.19M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Eli Lilly And LLY:US $ 48187M 378M
Emergent Biosolutions EBS:US $ 2867.5M 47.7M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Henry Schein HSIC:US $ 8420.75M 296.69M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Lannett LCI:US $ 690.87M 7.13M
Novartis NOVN:VX SF 121209M 2806M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Phibro Animal Health PAHC:US $ 836.04M 5.28M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Takeda 4502:JP Y 12560273M 96961M
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
Xeris Pharmaceuticals Inc XERS:US $ 131.26M 20.24M
Zoetis ZTS:US $ 13705M 364M